Skip to content

Clinical trials

Terminated Ovarian Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Status: Terminated Country / region: Australia Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20121
20152
20182
20192
20203
20213
20225
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fusion Pharmaceuticals Inc.2
Morphotek2
Novartis Pharmaceuticals2
Pfizer2
AbbVie1
Actym Therapeutics, Inc.1
Amgen1
Aminex Therapeutics, Inc.1
Elevation Oncology1
Haihe Biopharma Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms23
Breast Neoplasms8
Fallopian Tube Neoplasms6
Pancreatic Neoplasms5
Urinary Bladder Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Carcinoma, Renal Cell4
Colorectal Neoplasms4
Endometrial Neoplasms4
Esophageal Neoplasms4

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.